Emmanuel Bergot

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

Athénaïs Boucly, Jason Weatherald, Laurent Savale et al. · European Respiratory Journal · 2017 · 685 citations · Full text

Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

David Montani, Emmanuel Bergot, Sven Günther et al. · Circulation · 2012 · 636 citations

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study

Olivier Sitbon, Xavier Jaïs, Laurent Savale et al. · European Respiratory Journal · 2014 · 375 citations · Full text

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

Pierre‐Régis Burgel, I. Durieu, R. Chiron et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 227 citations